🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our publication on the prognostic benefits of cutaneous immune-related adverse events, validating our previous population-level findings. Special thanks to Zhang Shijia, Kimberly Tang, Guihong WAN, and the rest of the team. #dermtwitter #MedTwitter

Very grateful for such an incredible opportunity!! Thank you Eugene Semenov, MD

Amazing work!! Ahmad Rajeh!

🚨New Review🚨 - Oncology and Dermatology Rating: ⭐⭐⭐⭐⭐ Title: "Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A Multi-institutional cohort study" Reviewer: Maulik Dhandha, MD Link 👉 researchhub.com/paper/1278304/…

Excited to share our JAMA Dermatology viewpoint bitly.ws/3fSDp examining immunotherapy in localized melanoma. Big congrats to Hannah Rashdan in my lab for leading the piece, which was also a hot topic @ the most recent Melanoma Research meeting! Thx to Ade Adamson, MD MPP for his collab.

Still not over this week! 😍 Incredibly grateful and thrilled for the opportunity to become a dermatologist at Georgetown’s Med-Derm Program!!! To my friends, family, and mentors Eugene Semenov, MD Thank you, thank you, thank you!! DC here I come! #Match2024 #dermtwitter

Very excited to share our Delphi consensus guidelines to diagnosing dermatologic immunotherapy toxicites. Incredible team effort from more than 30 experts, including Steven Chen 陳持威, MD, MPH, MHPEd Kerry Reynolds, Jarushka Naidoo, and Nicole LeBoeuf.

Extremely proud of the team, especially Guihong WAN, Sara Khattab, MD, and Wenxin Elmon Chen for our The Lancet Oncology study on multi-organ toxicities from checkpoint blockade, providing a roadmap for prognosticating outcomes via the lens of immunotherapy toxicities: tinyurl.com/yc3t7amf